Login Register Cart 0
Generic placeholder image

Current Drug Safety

Editor-in-Chief

ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Assessment of Drug Usage Pattern among Bronchial Asthma Patients in a Tertiary Care Teaching Hospital, Tamilnadu: A Cross-sectional Study

Author(s): Kala Paneerselvam*, Kiran Belur and Jamuna Rani Raveendran

Volume 18, Issue 4, 2023

Published on: 13 January, 2023

Page: [534 - 539] Pages: 6

DOI: 10.2174/1574886318666221213102924

Price: $65

Abstract

Background: Asthma is a chronic inflammatory disease of the small airways. Chronic inflammation often causes hyper responsiveness of airways with wheezing, breathing difficulty, cough and chest tightness.

Objective: The present study aimed to evaluate the drug usage pattern of anti-asthma drugs among asthma patients.

Methods: The present study was a prospective, observational cross-sectional study carried out among 422 outpatients being treated at the respiratory medicine department, SRM Medical College Hospital and Research Centre. Data regarding the prescribing indicators and patient indicators were collected from the patients’ prescription slips and entered in the preformed proforma. Prescribing indicators were taken into consideration in evaluating the rationality of prescriptions.

Results: In the present study, 49% of patients were between the age group of 20-40 years. Genderwise distribution showed 58.05% of males and 41.95% of females. A family history of asthma was seen in 68% of the study population. The present study reported smoking among 51% and tobacco chewing in 21% of the study population. Low economic strata were observed in 77.9% of the study population. According to asthma grading, 65.8% were in the mild intermittent, and 25% were in the mild persistent group. Patients were on β2 agonists (35.4%) and corticosteroids (32%). The most commonly used fixed drug combination was a short-acting β2 agonist with corticosteroid (40.5%). A total of 68% of drugs were used by the inhalational route and 29% by the oral route.

Conclusion: The findings showed that, the most frequently prescribed drug was a short-acting β2 agonist with corticosteroid in a fixed-dose combination via inhalational route.

« Previous Next »
Graphical Abstract

[1]
British Thoracic Society and Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Clinical Guideline. 2014. Available from: https://www.brit-thoracic.org.uk/document-library/guidelines/asth ma/btssign-asthma-guideline-2014/
[2]
Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396(10258): 1204-22.
[http://dx.doi.org/10.1016/S0140-6736(20)30925-9] [PMID: 33069326]
[3]
Barnes PJ. Similarities and differences in inflammatory mechanisms of asthma and COPD. Breathe 2011; 7(3): 229-38.
[http://dx.doi.org/10.1183/20734735.026410]
[4]
Global Asthma Network. The global asthma report. 2018. Available from: http://www. globalasthmareport.org/resources/global_asthma_repo rt_2018.pdf (Accessed on: Feb 22, 2022).
[5]
Rodolf M. Pascual, JeRay J Johnson, Stephen P Peters. Asthma: Clinical presentation and Management. In: Fishman’s Pulmonary Diseases and Disorders. (4th ed.). McGraw-Hill: New York 2008; pp. 815-36.
[6]
Haslett C. Asthma Cellular and humeral mechanisms. Crofton and Douglass respiratory disease 2008 Jan 30; 5: 907-21.
[7]
Global Initiative for Asthma. Global strategy for asthma management and prevention: NHLBI/WHO workshop report. Bethesda, MD: National heart, lung, and blood institute 2006.
[8]
Global Initiative for Asthma. Global strategy for asthma management and prevention. 2020. Available from: www.ginasthma.org (Accessed on: Feb 22, 2022).
[9]
Patterson C H. (1995); Joint Commission on Accreditation of Healthcare Organizations. Infection control and hospital epidemiology, 16(1): 36-42.
[http://dx.doi.org/10.1086/647001]
[10]
Kubacka RT. A primer on drug utilization review. J Am Pharm Assoc 1996; 36(4): 257-61.
[11]
Network GA. The Global Asthma Report 2018. http://globalasthmareport.org/management/india.php (Accessed on: 28 Feb 2022).
[12]
Kharazi SR, Kumar P. Assessment of the Drug Use Evaluation for Bronchial Asthma in a Tertiary Care Hospital, Bangalore, India. Archives of Pharmacy Practice¦ Volume. 2020 Oct; 11; (S4): 53.
[13]
Montealegre F, Chardon D, Tarrats H. Environmental factors precipitating bronchial asthma exacerbations in southern Puerto Rico: a pilot study. J Asthma 1993; 30(3): 219-27.
[http://dx.doi.org/10.3109/02770909309054520] [PMID: 8325831]
[14]
London SJ, James Gauderman W, Avol E, Rappaport EB, Peters JM. Family history and the risk of early-onset persistent, early-onset transient, and late-onset asthma. Epidemiology 2001; 12(5): 577-83.
[http://dx.doi.org/10.1097/00001648-200109000-00019] [PMID: 11505179]
[15]
Wani R. Socioeconomic status scales-modified Kuppuswamy and Udai Pareekh’s scale updated for 2019. J Family Med Prim Care 2019; 8(6): 1846-9.
[http://dx.doi.org/10.4103/jfmpc.jfmpc_288_19] [PMID: 31334143]
[16]
Hedlund U, Eriksson K, Rönmark E. Socio-economic status is related to incidence of asthma and respiratory symptoms in adults. Eur Respir J 2006; 28(2): 303-410.
[http://dx.doi.org/10.1183/09031936.06.00108105] [PMID: 16540503]
[17]
Burute SR, Shah RD, Ramanand S, Murthy M, Shah N, Kumbhar A. Drug utilization study in patients with bronchial asthma of a tertiary care hospital in Western Maharashtra. Indian J Allergy Asthma Immunol 2019; 33(2): 105-11.
[http://dx.doi.org/10.4103/ijaai.ijaai_17_19]
[18]
He Z, Feng J, Xia J, Wu Q, Yang H, Ma Q. Frequency of signs and symptoms in persons with asthma. Respir Care 2020; 65(2): 252-64.
[http://dx.doi.org/10.4187/respcare.06714] [PMID: 31662445]
[19]
Rajathilagam T, Sandozi T, Nageswari AD, Paramesh P, Rani Jamuna R. Drug utilization study in bronchial asthma in a tertiary care hospital. Int J Pharm Appl 2012; 3(2): 297-305.
[20]
Rafeeq MM, Murad HAS. Evaluation of drug utilization pattern for patients of bronchial asthma in a government hospital of Saudi Arabia. Niger J Clin Pract 2017; 20(9): 1098-105.
[http://dx.doi.org/10.4103/njcp.njcp_378_16] [PMID: 29072231]
[21]
Kumar VB, Thankachan TM, Amanapu A, Chandra DS, Krishnan SP. Study of prescribing pattern and impact of pharmaceutical care in bronchial asthmatic paediatric patients in a tertiary care teaching hospital. Indian Journal of Pharmacy Practice 2015; 8(1)
[http://dx.doi.org/10.5530/ijopp.8.1.8]
[22]
Garje YA, Suman RK, Kumar R, Deshmukh YA, Patra V. Prescribing patterns and pharmacoeconomic analysis of drugs used in pediatric asthma patients at tertiary care hospital. World J Pharm Pharm Sci 2014; 3: 1448-65.
[23]
Crossingham I, Turner S, Ramakrishnan S, et al. Combination fixed-dose β agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane systematic review. BMJ Evidence-Based Medicine 2022 Jun 1; 27(3): 178-84.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy